Approval · Notice of Compliance 35932 · 2025
EVRYSDI: Notice of Compliance 35932
Issued August 28, 2025
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 35932
- Date
- August 28, 2025
- Company
- Hoffmann-La Roche LimitedMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product Monograph reformatted to the Master Template. Update to the Product Monograph with new safety information. Addition of new dosage form: Tablet. Addition of new strength: 5 mg
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| EVRYSDI | Not yet assigned | — |
| EVRYSDI | 02560747 | Marketed |